arrow
M

Maria K. Angelopoulou

national and kapodistrian university of athens
H指数:33
被引数:4,045

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Impact of Chemotherapy on Gonadal Function in Female Patients with Hodgkin and Non-Hodgkin Lymphoma: A Comprehensive Analysis of Hormonal Kinetics and Implications for Fertility and Contraceptive Planning

化疗对霍奇金和非霍奇金淋巴瘤女性患者性腺功能的影响:激素动力学综合分析及其对生育能力和避孕计划的启示

Cancers
IF4.4
2026-09-040
OA
Venetoclax–Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview

复发/难治性CLL中c-btki暴露后维尼托克-利妥昔单抗和新兴治疗策略: 真实世界队列和文献综述

2025-09-290
OAAI
Validation of the simplified geriatric prognostic index in a Hellenic database of older patients (≥ 70 years old) with diffuse large B-cell lymphoma and similar disorders

简化版老年预后指数在希腊老年患者(≥70岁)弥漫性大B细胞淋巴瘤及类似疾病数据库中的验证

2025-07-170
OA
Bloodstream Infections Due to Multidrug-Resistant Gram-Negative Organisms in Hematopoietic Stem Cell Transplant Recipients: A Multicenter Case-Control Study in a High-Prevalence Area

多重耐药革兰阴性菌引起的血流感染在造血干细胞移植受者中的发生:一项在高流行地区的多中心病例对照研究

2025-05-140
OAAI
Clinical features, treatment options and outcomes in primary cutaneous B-cell lymphomas: a real-world, multicenter, retrospective study
2024-11-110
OA
The Prognostic Significance of Serum β2- Microglobulin Levels (sβ2m) in Diffuse Large B-Cell Lymphoma (DLBCL)

血清β2-微球蛋白水平(sβ2m)在弥漫大B细胞淋巴瘤(DLBCL)中的预后意义

BLOOD
IF23.1
2024-11-050
PRE
Nationwide Multicenter Real-World Survey of CAR-T Cell Toxicity Prophylactic and Treatment Management Strategies

全国多中心真实世界CAR-T细胞毒性预防及治疗管理策略调查

BLOOD
IF23.1
2024-11-050
PRE
Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin and Steroids (PolaRCHP) in Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Real-Life Experience in Greece

Polatuzumab Vedotin、Rituximab、Cyclophosphamide、Doxorubicin和类固醇(PolaRCHP)用于初治弥漫性大B细胞淋巴瘤(DLBCL):希腊的真实世界经验

BLOOD
IF23.1
2024-11-050
PRE
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL

慢性淋巴细胞白血病患者的治疗策略和治疗顺序: 欧洲CLL研究计划ERIC的国际研究

2024-09-170
OAAI
PET for Response Assessment to R-da-EPOCH in Primary Mediastinal Large B-cell lymphoma: Who Is Worthy to be Irradiated?
2023-11-012
OAAI
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

CLL历史上的其他恶性肿瘤: ERIC进行的一项国际多中心研究,欧洲CLL研究倡议,和谐

2023-11-016
OAAI
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era

利妥昔单抗时代原发性纵隔大b细胞淋巴瘤患者中枢神经系统复发的发生率及危险因素分析

2022-12-088
PRE
Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors
2022-07-056
OAAI